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Summary  16	
Stroke is a complex, time-sensitive, medical emergency that requires well-functioning 17	
systems of care to optimise treatment and improve patient outcomes. Education and training 18	
campaigns are needed to improve both the recognition of stroke among the general public and 19	
the response of emergency medical services. Specialised stroke ambulances (mobile stroke 20	
units) have been piloted in many cities to speed up the diagnosis, triage and emergency 21	
treatment of people with acute stroke symptoms. Hospital-based interdisciplinary stroke units 22	
remain the central feature of a modern stroke service. Many have now developed a role in the 23	
very early phase (hyperacute units) plus outreach for patients who return home (early 24	
supported discharge services). Different levels (comprehensive and primary) of stroke centre 25	
and telemedicine networks have been developed to coordinate the various service 26	
components with specialist investigations and interventions including rehabilitation. Major 27	
challenges include balancing the resources for stroke across the whole patient journey 28	
including the rapid, accurate triage of those patients who require highly specialised treatment 29	
in comprehensive stroke centres and developing technology to improve communication 30	
across different parts of a service. (178 words) 31	
Introduction  32	
Stroke is recognised as a global health problem1 and in many high income countries, stroke 33	
accounts for over 5% of health expenditure.2 The organisation of services has gained 34	
particular prominence over the last two decades with the recognition that the timely delivery 35	
of best-practice stroke care can improve patient outcomes.2  36	
We review the organisation of services for people who have had a stroke in a high-income 37	
country, with particular reference to Western Europe, North America, and Australia. While 38	
we try to focus on evidence of effectiveness and efficiency of stroke services, other factors 39	
may influence the organisation of services including; a) the local health care culture and 40	
economy (particularly whether a private or publicly-funded service), b) the needs and 41	
expectations of different patient groups and the degree to which they are prioritised, and c) 42	




An ideal stroke service should deliver the care required by patients and their families in the 45	
most effective, efficient, equitable, and humane manner possible. It would cover the needs of 46	
people with suspected acute stroke and be integrated to provide a seamless interdisciplinary 47	
(medical, nursing, allied health), specialised service from time of presentation until discharge 48	
from the stroke service. While many components will be stroke specific, some may overlap 49	
with other services (e.g. ambulance, emergency department, neurology, rehabilitation, care of 50	
the elderly, palliative care). Although the focus tends to be on ischaemic stroke the same 51	
principles apply to intracerebral haemorrhage. We have not included primary stroke 52	
prevention or long-term care, as these are beyond the scope of this review.  53	
Several evidence-based acute stroke treatments can reduce disability but are very time-54	
sensitive, in particular reperfusion treatments for ischaemic stroke such as intravenous 55	
thrombolysis3 and endovascular thrombectomy4. A major barrier to such treatments is that 56	
patients do not arrive to hospital within the recommended time windows for treatment.5 57	
While recent advances in the use of imaging technology has meant that time windows for 58	
reperfusion therapies may be extended in selected cases,6 equity of access to hospitals with 59	
advanced imaging modalities remains a challenge. Other barriers include lack of specialist 60	
services and equipment to support diagnosis and treatment decisions.  61	
Figure 1 provides an idealised summary of an patient journey commencing with the prompt 62	
recognition and response to symptoms, rapid diagnosis and reperfusion (if appropriate), and 63	
early measures to prevent complications (including recurrent stroke) and promote recovery, 64	
rehabilitation and return to normal living.7,8 For simplicity we focus on the typical patient 65	
pathway. Some services aimed at specific subgroups (for example vascular prevention 66	
services for patients not admitted to hospital) are beyond the scope of this review. The 67	
various interventions currently available to address these challenges within high-income 68	
health systems are also summarised in Figure 1. These interventions will be further discussed 69	
in this article. 70	
Ideally, all our decisions about stroke services should be based on robust evidence from 71	
randomised trials or similar quality evidence. However, such trials are complex and 72	
challenging to carry out and it is frequently difficult to develop, describe, and measure the 73	
intervention satisfactorily.9 We have used information from randomised trials, high quality 74	
cohort studies and recent clinical practice guidelines. Planners should be aware that lack of 75	
evidence of benefit is not the same as evidence of lack of benefit. 76	
Search strategy and selection criteria  77	
This is a pragmatic review where key word searches were undertaken to identify relevant 78	
literature using Medline and other databases. We also searched the Cochrane Library from 79	
first publication to 12 May 2020 with the search terms “stroke” and various topic specific 80	
terms (such as “telemedicine”, “telestroke”, “telerehabilitation”). We also searched the 81	
Cochrane Stroke Group section of the Cochrane Library containing 197 reviews and 82	
protocols of which 17 reviews and protocols were relevant to this review. We also reviewed 83	
the most up-to-date clinical practice guidelines, which provided a more consensual analysis 84	
of the evidence. We specifically sought guidelines published in the last three years from 85	
Europe, North America, and Australia. Finally, we crosschecked the references identified for 86	
appropriate information.  87	
 88	
Components of stroke services 89	
Education and training campaigns  90	
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A major focus of public health initiatives has been to improve the time to treatment for 91	
patients with ischaemic stroke. There are several inter-related reasons that contribute to 92	
patients with stroke experiencing delays with the provision of reperfusion therapies. In a 93	
recent systematic review,8 four categories of factors associated with delays were identified: 1) 94	
patient-related factors, plus health system factors related to 2) training, 3) resources, and 4) 95	
lack of coordination. In another similar systematic review,10 the authors reported that 96	
patients’ attitudes, knowledge, and education were associated with time to presentation to 97	
hospital after stroke. Visiting the primary care physician after stroke was associated with 98	
delayed presentation. 99	
Various strategies directed at the public and emergency medical services appear to improve 100	
stroke recognition and time to presentation and treatment for people with stroke. A systematic 101	
review of 39 studies of stroke knowledge conducted in the UK, North America, Asia and 102	
Australia11 provided an illustration of the wide variability between studies in terms of the 103	
ability of the public to name stroke risk factors, to name signs and symptoms of stroke, and 104	
the decision to call emergency medical services. In other studies it was also found that the 105	
general public would opt to contact or attend their primary care physician first, rather than 106	
emergency medical services following onset of their symptoms.11 107	
Public awareness campaigns are designed to improve time to diagnosis and treatment metrics. 108	
However, of the studies of educational campaigns and stroke awareness conducted in Europe, 109	
Asia, North America, and Australia, few have been found to be effective for improving 110	
response times after stroke onset.12 There has been limited research on how knowledge and 111	
attitudes of paramedic staff, emergency medical staff and primary care physicians can reduce 112	
delays within stroke care. In one study, primary care physicians stated that stroke and TIA 113	
were medical emergencies, but would admit patients to hospital as a medical emergency only 114	
in approximately two-thirds of case vignettes with clear stroke symptoms.13 However, 115	
educational interventions for emergency medical services can improve access to thrombolysis 116	
and several validated pre-hospital stroke screening tools used by paramedics can improve the 117	
accuracy of paramedic diagnosis.14,15 Similar tools have been adapted for use by emergency 118	
medical services to identify and rapidly transfer patients with suspected stroke to hospitals 119	
able to provide thrombolysis16 or for endovascular thrombectomy.17 Such protocols are 120	
particularly relevant to provide pre-hospital triage, in areas underserved with specialist stroke 121	
services.   122	
Until awareness among the general public is greater, educational interventions to improve the 123	
recognition of stroke in general practices and by emergency medical services are essential.  124	
Mobile Stroke Unit ambulances 125	
A relatively novel solution to minimise delays to diagnosis and treatment is to bring the 126	
stroke team and necessary diagnostic tools to the patient, prior to hospital arrival. Within 127	
some highly developed health systems, there are specialised stroke ambulances, often called 128	
mobile stroke units (MSUs), that expedite diagnosis, triage, and treatment by bringing CT 129	
scanning capability and a point-of-care laboratory to a patient with suspected stroke. 130	
Currently, MSUs are operational in over 20 cities, mainly in North America and Europe.18,19 131	
While models of operation vary, MSUs are generally staffed with specialised stroke 132	
clinicians (advanced practice nurses, stroke specialists with or without telemedicine support) 133	
so that patients can be diagnosed with stroke and provided thrombolysis if eligible prior to 134	




When the provision of thrombolysis provided by several MSU services was compared to 137	
registry data, a larger proportion of MSU patients was treated faster after stroke18  with a 138	
trend towards better functional outcome.22 In studies utilising a week-by-week randomisation 139	
procedure in Germany, patients treated by the MSU had a shorter alarm to treatment time 140	
compared to patients treated with standard care; median difference of 44 minutes in 141	
Homburg,21 and 25 minutes in Berlin.23  142	
MSUs also raise the possibility of providing other pre-hospital treatments, including the early 143	
reversal of warfarin, dabigatran or other anticoagulant after ICH or prior to thrombolysis.24 144	
Having a pre-hospital diagnosis may also enable efficiencies with appropriate transfer to 145	
hospitals for treatment of stroke mimics,25 or the provision of endovascular thrombectomy,26 146	
or neurosurgery for ICH.27  147	
The limited information available has provided mixed views on whether MSUs represent 148	
good value for investment. One evaluation of MSUs concluded they were likely to be cost 149	
effective, with health benefits attributable to improvements in the provision of reperfusion 150	
therapies.28,29	However, other authors have been more cautious, citing the limited evidence to 151	
support reliable analyses.30 152	
Stroke Centres (Comprehensive Stroke Centres and Primary Stroke Centres) 153	
Initiatives to improve stroke care through the provision of stroke centres (Comprehensive and 154	
Primary Stroke Centres) started in the North America31 but have also been developed in 155	
Australia and Europe.32 The objective was to improve the delivery of evidence-based stroke 156	
care by establishing two levels of specialist stroke centres (see summary in Table 2).  157	
Primary Stroke Centre (PSC) – typically this is a more local service provided by a hospital 158	
with the necessary staffing, infrastructure, and programmes to manage the majority of 159	
patients with acute stroke.31 In practice, these tend to be closely aligned with the stroke unit 160	
concept outlined below. 161	
Comprehensive Stroke Centre (CSC) – typically this is a centralised, regional service based 162	
in a hospital that can provide care to patients with the most complex stroke needs including 163	
specialist investigations and interventions.31 These initiatives gained further impetus with the 164	
publication of trials demonstrating the benefit of mechanical thrombectomy for large vessel 165	
occlusion stroke,33 an intervention that requires centralisation in a neuroscience centre. CSCs 166	
are also considered to provide neurosurgical or neuroradiological interventions for cerebral 167	
aneurysms, arteriovenous malformations, and decompressive neurosurgery. It was anticipated  168	
that CSCs could provide a higher quality of care but would not have the capacity to manage 169	
the patient numbers for a whole region. 170	
Empirical studies comparing the impact of CSCs and PSCs in Europe34 and United States35,36 171	
indicate that both approaches have achieved improvements in the quality and outcome of care 172	
compared with non-specialist care in general hospitals. When CSCs and PSCs were directly 173	
compared, both achieved similar quality measures for acute ischaemic stroke patients. 174	
Although the process of care tended to be more efficient in the larger CSCs (in particular the 175	
speed and delivery of acute reperfusion therapies), important patient outcomes such as in-176	
hospital mortality, recovery of mobility, and discharge home were found to be comparable 177	
after adjusting for casemix variables. In the North American study36 the risk adjusted 178	
mortality was actually higher in CSCs than PSCs but this could possibly be due to residual 179	
confounding.   180	
These observational studies indicate that both CSC and PSC approaches appear to improve 181	
the quality of care and patient outcomes. While CSCs are required for the most complex 182	
stroke interventions (such as mechanical thrombectomy or neurosurgical interventions), the 183	
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needs of many acute stroke patients can normally be met within PSCs. This then raises the 184	
challenge of how to achieve the rapid, accurate triage of appropriate patients in the 185	
prehospital setting from their local stroke service to a regional CSC (see below).   186	
Some geographical situations, such as in very low population density areas, will not allow the 187	
implementation of specialized stroke services such as PSCs. In such environments, acute 188	
stroke patients should be referred to appropriate specialized facilities. To avoid critical 189	
delays, time sensitive thrombolysis should be enabled before transportation. Telemedicine 190	
can help to make smaller hospitals “tPA-ready” (see TeleStroke section below). Even 191	
hospitals which provide thrombectomy may lack Neurosurgery or Neuro-intensive care 192	
services. In such cases, transfer to full-service facilities should be timely and ideally through 193	
an interdisciplinary consensus (e.g. within telemedicine-enabled case consultations). Whether 194	
ground ambulances or helicopters are used for emergency interhospital transport will depend 195	
on distance, traffic and availability, and should be monitored as part of quality assessment.  196	
Stroke unit care 197	
Stroke unit care is now established as the central feature of a modern stroke service in most 198	
higher income countries.37 Compared with care in a general medical or neurology ward, 199	
admission to a stroke unit can result in more patients surviving, returning home, and 200	
regaining independence; number needed to treat (NNT) of around 20 for one extra 201	
independent survivor.38 Clinical trial evidence indicates that stroke unit care can benefit a 202	
broad range of patients irrespective of age, sex, stroke severity, or stroke type although the 203	
survival benefit is greater with more severe stroke. The core features of stroke unit care 204	
include; a) a discrete ward area, b) specialist medical, nursing, and therapy staff with an 205	
expertise in stroke, c) multidisciplinary team working through regular meetings, and d) 206	
standard protocols to address common challenges and reduce the risk of complications. 207	
While the evidence strongly supports the concept of providing care in a specialist stroke unit, 208	
in practice, people have tried to deliver this type of care in a variety of different ways (Table 209	
1). In recent years many stroke services have promoted a model of care ('hyper-acute' stroke 210	
units) equipped to support reperfusion therapies or other acute interventions. These newer 211	
service models have been evaluated in non-randomised studies39,40 but not formally tested in 212	
randomised controlled trials. Clinicians and planners should ensure that every stroke patient 213	
receives the core service characteristics described in the randomised trials of stroke unit 214	
care38 and that the patient experiences a continuous process of stroke unit care from initial 215	
assessment to discharge from hospital.41 This is particularly important as stroke unit care 216	
appears to benefit the majority of patients who are not eligible for reperfusion therapies.38 217	
The ideal size and configuration of services within a particular hospital site will depend on 218	
other factors such as rurality and other services and resources available.42,43 Most randomised 219	
trial research has been carried out on comprehensive stroke units, which combine acute care 220	
and rehabilitation, and rehabilitation stroke units. Mixed rehabilitation units may have a role 221	
in small hospitals or very specialised services such as those for young adult rehabilitation. 222	
Some countries have a tradition of admitting patients with stroke to intensive care units. 223	
While this approach has an intuitive appeal, it lacks evaluation in rigorous clinical trials. 224	
Transfer from hospital to community 225	
A major area of concern for patients and caregivers is the period of transition from hospital 226	
back home. Patient surveys often highlight a sense of abandonment and concern at this stage 227	
in the patient journey.44,45 One approach to addressing these concerns is through careful 228	
preparation including; a) provision of adequate information and training, b) home 229	
assessments prior to discharge, and c) training and education with carers and family.46 230	
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However, such measures often fail to meet all reported needs and more recently early 231	
supported discharge (ESD) services have been developed to improve this period of 232	
transition.47 233	
The ESD concept is to accelerate the discharge home from hospital but also provide more 234	
rehabilitation in the home setting. This package of care is typically provided by a 235	
multidisciplinary team of nurses and therapists with some medical input. A typical care 236	
pathway48 is outlined in Figure 2. 237	
To date, many small randomised trials have tested this approach and provide evidence that 238	
patients who receive input from an ESD team can return home earlier and have a greater 239	
chance of remaining at home and regaining independence in daily activities. The NNT is 240	
approximately 20 to obtain one extra independent individual. These impressive results appear 241	
to require a well-resourced, co-ordinated, multidisciplinary ESD team with a focus on 242	
patients with mild to moderate disability. The full range and role of such services is not well 243	
understood. Other forms of post-hospital support may include specialised nurse-led outpatient 244	
clinics and day hospitals.  245	
Continuing rehabilitation and reintegration to regular living 246	
This aspect of the patient journey appears to have the greatest diversity of service delivery 247	
and most diverse research models, possibly reflecting the unique challenges that individual 248	
patients may face after stroke. Recommendations tend to focus on processes of care with less 249	
clear advice on what interventions should be delivered. For example the Action Plan for 250	
Europe37 recommends; a) providing a documented plan for community rehabilitation and 251	
self-management support for all patients with stroke with residual difficulties on discharge 252	
from hospital, b) ensuring that all survivors and caregivers have a review of the rehabilitation 253	
and other needs at three to six months after stroke and annually thereafter, and c) offering 254	
physical fitness programmes for those living independently in the community. One potential 255	
advantage of ESD teams is to provide a structure to link hospital care to community-based 256	
services to coordinate ongoing rehabilitation. However much more research is needed into 257	
how best to improve this phase of the journey. 258	
Telemedicine networks (acute telemedicine and telerehabilitation) 259	
Many patients can miss out on effective treatments after stroke because of geographical 260	
isolation and/or a lack of access to specialist medical or allied health services. Since the era 261	
of stroke thrombolysis in the late 1990s, many regions have sought to reduce inequities in 262	
accessing treatment for ischaemic stroke through telecommunications.49 The establishment of 263	
telemedicine programs for acute stroke treatment is based on three important factors.50 264	
Firstly, diagnosis is possible with access to cerebral imaging scans that are now easy to 265	
transmit electronically and stroke symptoms can be assessed via audio-visual examination.51 266	
Therefore, remote controlled videoconferencing combined with teleradiology offers an 267	
appropriate tool for stroke assessment. Second, acute stroke workup requires expertise from 268	
stroke specialists who are not always available onsite in many smaller, particularly rural 269	
areas. Third, because the effects of recanalisation therapies are highly time dependent and 270	
favour immediate decision-making in the local hospital in order to start thrombolysis or when 271	
indicated, to transfer appropriate patients to an endovascular thrombectomy capable hospital.  272	
While acute telestroke has been evaluated in multiple domains52–54 and has now become a 273	
widespread application in many regions,55-56 telerehabilitation approaches are less well 274	
developed57,58 and further development and investigation is urgently needed. 275	
Appropriate telestroke assessment and decision making requires meeting technological and 276	
organisational quality standards including remote control and broadband streaming for 277	
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videoconferencing, rigorous data protection, standard operating procedures, together with 278	
accreditation for service providers, and clinical quality management and reviews.52 279	
Telestroke is used in different forms ranging from exclusive remote consultation e.g. for 280	
indicating thrombolytic treatment59 to comprehensive networks enabling smaller hospitals to 281	
run local (tele-) stroke units.60 282	
Evidence for telestroke 283	
Investigations across multiple scenarios have shown equivalent reliability and validity of 284	
remote neurological assessment51,61 and imaging reading62,63 compared to onsite 285	
examinations. This prompted the use of telemedicine to support delivery of intravenous 286	
thrombolysis in hospitals without full-time stroke specialists available.60 Randomized studies 287	
showed there was better accuracy of diagnosis and decision-making when based on video 288	
examination compared to telephone consultation only64,65 while other controlled studies 289	
found equivalent safety and functional outcomes after telemedicine-based administration of 290	
thrombolysis in smaller hospitals compared to its application in larger experienced stroke 291	
centers.66–68 Such systems can achieve similar levels of quality (as measured with door-to-292	
needle times)69,70 as well as reductions in complications after thrombolysis such as 293	
symptomatic intracerebral bleeding.68 In a large controlled study with a matched-hospitals 294	
design, telemedicine embedded in such a comprehensive telestroke network concept resulted 295	
in significantly better quality measures and patient outcomes up to 30-months follow-up.71,72 296	
Telestroke networks are cost-effective from a societal,73 health insurers,74 and a hospital75 297	
perspective. Importantly, this model of care can improve the triage of patients located outside 298	
metropolitan areas in determining those eligible for endovascular thrombectomy.76 Telestroke 299	
may also facilitate more hospitals being included in stroke clinical trials by enabling the 300	
identification of patients who might qualify for trials of new or improved therapies. 301	
Mobile telemedicine 302	
The higher bandwidth available in mobile telecommunication has facilitated the use of 303	
telemedicine in the prehospital field over more recent years.77,78 While videoconferencing 304	
based on third generation (3G) telecommunication standards failed to provide sufficient 305	
streaming stability77,79 several groups have reported reliable video-examination using 4G 306	
standard.80–82 In MSUs, telemedicine is also successfully used for transfer and interpretation 307	
of computer tomography (CT) scans.83,84 308	
Telerehabilitation 309	
The provision of physical rehabilitation,85 speech and language therapy,86 and occupational 310	
therapy87 can improve mobility, communication skills, and activities of daily living in 311	
survivors of stroke. As most rehabilitation treatments are provided in inpatient facilities, the 312	
duration of such treatment is restricted to a few weeks and resources are limited in long-term 313	
outpatient rehabilitation. Telerehabilitation comprising a remote administration or 314	
supervision of rehabilitation therapies could enhance the intensity of post-stroke 315	
rehabilitation, increase the duration of service provision, and at the same time be more 316	
convenient and less expensive than conventional rehabilitation.  317	
The evidence supporting telerehabilitation is variable. An initial systematic review found 318	
insufficient evidence to reach conclusions about the effectiveness of telerehabilitation,57 319	
while one including with studies up to 201788 reported evidence that telerehabilitation 320	
interventions were better or equivalent to conventional face-to-face therapy for motor, higher 321	
cortical, and mood disorders. In the most recent systematic review,58 positive effects of 322	
telerehabilitation on several outcomes were observed, but conclusive recommendations could 323	
not be made due to methodological and practical concerns. At present, we lack robust 324	
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evidence to support the widespread implementation of telerehabilitation, but it is likely to be 325	
useful particularly in areas with low population density or remote access to rehabilitation 326	
facilities. 327	
Coordination and monitoring of services for stroke  328	
Importance of prehospital triage  329	
Modern stroke incidence studies in high income countries89 indicate that approximately half 330	
of patients with ischaemic stroke will present with relatively mild but potentially important 331	
symptoms (NIHSS <5) that are outside the licence for thrombolysis or thrombectomy. Recent 332	
estimates90 indicate that approximately 25% of all ischaemic strokes could be eligible for 333	
medical thrombolysis and 10–12% eligible for endovascular treatment. The remaining 334	
patients will still require high quality stroke care. A major challenge for modern stroke 335	
services is to balance the delivery of high quality, local services with those that must be 336	
centralised in regional centres. This challenge has been addressed in a range of ways and the 337	
key elements are summarised in Figure 3. The crucial step is to be able to rapidly and 338	
accurately select those patients who need to be moved urgently to the centralised service for 339	
consideration of specialist investigations and treatment. The approaches to achieving this 340	
have included; a) rapid selection tools such as clinical scoring systems,14,92 b) MSUs,18 c) 341	
telemedicine links,52 or d) combinations of the above. The ideal balance between primary 342	
(‘ship’) and secondary transfer (‘drip-and-ship’) approaches for patients is a subject of 343	
ongoing research and likely to vary between regions.92 344	
A basic agreement with emergency medical services should be in place to ensure that patients 345	
with symptoms suspicious of acute stroke are delivered to stroke-ready hospitals. Multiple 346	
prehospital scales for identification of patients with large vessel occlusion in the field have 347	
been published in recent years. Authors of systematic reviews have concluded that no scale 348	
predicts large vessel occlusion with both high sensitivity and high specificity.93 Prospective 349	
controlled studies evaluating their clinical benefits are missing. So long as vessel imaging is 350	
not available in standard ambulances, such scales may be useful to route patients to the ideal 351	
facility. However, local information on distances from scene to different hospitals, total 352	
transfer times and times of in-hospital procedures both in PSCs and CSCs need to be included 353	
in probabilistic models94 – ideally supported by online tools to aid decision-making. 354	
Monitoring service quality 355	
With the growth of clinical guidelines and concerns about variations in practice between 356	
hospitals and equity of access to best-practice management for acute stroke, monitoring the 357	
quality of care has become very important. The essence of the available evidence is that as 358	
many patients as possible should receive evidence-based treatments with minimal time 359	
delays. Regular stroke quality monitoring must therefore include the proportions of patients 360	
receiving (and delays to receiving); Stroke Unit care, intravenous thrombolysis and 361	
mechanical thrombectomy. The continuum of care should also be evaluated starting with 362	
prehospital emergency care and triage to the optimal facility, multiprofessional in-hospital 363	
management and stroke aftercare tailored to individual patient needs. However, this is more 364	
difficult because of the multiple sectors involved. 365	
While local registries can provide valuable information to the participating sites, simple 366	
comparisons between hospitals are unreliable for reporting trends in demographics, access to 367	
interventions, and outcomes. Standardised data collection via national audits or state-wide 368	
registries are to be encouraged (Table 3). In a recent review of national stroke registries only 369	
26 countries had a national registry for acute stroke care monitoring.95 In countries that have 370	
a national clinical quality registry of stroke care to enable standardised collection of data to 371	
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monitor acute stroke care in hospitals, the reporting of the data (and responding to the 372	
findings) has led to improvements in the quality of care, patient outcomes, and health 373	
policy.96,97 Large scale observational studies35,36,98 have shown impressive improvements in 374	
patient outcomes.  375	
Conclusions  376	
While the hospital stroke unit remains the central component of a modern stroke service 377	
major developments have taken place to streamline the systems of care and improve the 378	
speed of recognition, response, triage, and delivery of acute treatments to people with stroke 379	
symptoms. The development of new hyper-acute investigations and treatments has driven the 380	
development of centralised (comprehensive) stroke centres but there remains the challenge of 381	
how to optimise the triage of appropriate patients to these services while maintaining high 382	
quality local services for the majority who will not require this level of care. Future initiatives 383	
are likely to see ongoing development of telemedicine networks and possibly mobile stroke 384	
units to improve rapid decision making. In the future, technology may be further exploited to 385	
facilitate communication between service providers, to facilitate the transition to home, and 386	
provide ongoing support for rehabilitation including programs such as early supported 387	
discharge services and telerehabilitation. 388	
Declaration of Interests 389	
Dr. Langhorne reports grants from Chief Scientist's Office, Chest Heart and Stroke Scotland, 390	
and National Institute of Health Research,  outside the submitted work. Dr. Cadilhac reports 391	
grants from National Health and Medical Research Council, Boehringer Ingelheim, Shire, 392	
Medtronic, Heart Foundation (Australia), Stroke Foundation (Australia), Melbourne Health, 393	
outside the submitted work. Dr. Cadilhac is the Data Custodian for the Australian Stroke 394	
Clinical Registry and a member of the Pre-hospital Stroke Treatment Organization. Dr. 395	
Audebert reports grants from German Federal Ministry of Education and Research, Pfizer, 396	
German Stroke Foundation; personal fees from Bayer Vital, Boehringer Ingelheim, Bristol-397	
Myers-Squibb, Novo-Nordisk, Pfizer, and Takeda, outside the submitted work. No specific 398	
funding was used for this review. 399	
Author’s contributions 400	
Peter Langhorne drafted the review structure, wrote sections of the text, revised the 401	
manuscript and acts as guarantor. Heinrich Audebert, Dominique Cadilhac, Joosup Kim and 402	
Patrice Lindsay wrote sections of the text and revised the manuscript. All authors approved 403	
the final version. (4406 words) 404	
References  405	
1. Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 406	
188 countries, during 1990–2013: a systematic analysis for the Global Burden of 407	
Disease Study 2013. Lancet Neurol 2016; 15:913–24. 408	
2. Hankey GJ (Editor), Macleod M (Editor), Gorelick PB (Editor), Chen C (Editor), 409	
Caprio FZ (Editor), Mattle H (Editor). Warlow's Stroke: Practical Management, 4th 410	
Edition.  2019. Wiley Blackwell. ISBN: 978–1–118–49222–2. 411	
3. Emberson J, Lees KR, Lyden P, et al; Stroke Thrombolysis Trialists' Collaborative 412	
Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous 413	
thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual 414	




4. Goyal M, Menon BK, van Zwam WH, et al.; HERMES Collaborators. Endovascular 417	
thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual 418	
patient data from five randomised trials. Lancet 2016; 387:1723–1731. 419	
5. Meretoja A, Keshtkaran M, Tatlisumak T, Donnan GA, Churilov L. Endovascular 420	
therapy for ischemic stroke: Save a minute-save a week. Neurology 2017; 88(22): 421	
2123–7. 422	
6. Coutts SB, Menon BK. Late thrombolysis for stroke works, but how do we do it? 423	
Lancet 2019; 394:97–98. 424	
7. McDermott M, Skolarus LE, Burke JF. A systematic review and meta-analysis of 425	
interventions to increase stroke thrombolysis. BMC Neurol 2019; 19(1):86. 426	
8. Lachkhem Y, Rican S, Minvielle É. Understanding delays in acute stroke care: a 427	
systematic review of reviews. Eur J Public Health 2018; 28(3):426–33. 428	
9. Cadilhac DA, Fisher R, Bernhardt J. How to do health services research in stroke: A 429	
focus on performance measurement and quality improvement. Int J stroke 2018; 430	
13(2):166–174. 431	
10. Pulvers JN, Watson JDG. If Time Is Brain Where Is the Improvement in Prehospital 432	
Time after Stroke? Front Neurol 2017; 8:617–13.  433	
11. Jones SP, Jenkinson AJ, Leathley MJ, Watkins CL. Stroke knowledge and awareness: 434	
an integrative review of the evidence. Age and Ageing 2009; 39(1):11–22. 435	
12. Vondráčková L, Mikulík R. Public stroke education: Current status worldwide and 436	
projects to increase awareness in the Czech Republic. Cor et Vasa 2017; 59(6): e546–437	
e52. 438	
13. Roebers S, Wagner M, Ritter Martin A, Dornbach F, Wahle K, Heuschmann Peter U. 439	
Attitudes and Current Practice of Primary Care Physicians in Acute Stroke 440	
Management. Stroke 2007; 38(4):1298–303. 441	
14. Zhelev  Z, Walker  G, Henschke  N, Fridhandler  J, Yip  S. Prehospital stroke scales 442	
as screening tools for early identification of stroke and transient ischemic attack. 443	
Cochrane Database of Systematic Reviews 2019, Issue 4. Art. No.: CD011427. DOI: 444	
10.1002/14651858. 445	
15. Oostema JA, Chassee T, Baer W, Edberg A, Reeves Mathew J. Brief Educational 446	
Intervention Improves Emergency Medical Services Stroke Recognition. Stroke 2019; 447	
50(5):1193–200. 448	
16. Quain DA, Parsons MW, Loudfoot AR, et al. Improving access to acute stroke 449	
therapies: a controlled trial of organised pre-hospital and emergency care. Med J Aust 450	
2008; 189(8):429–33. 451	
17. Zhao H, Pesavento L, Coote S, et al. Ambulance Clinical Triage for Acute Stroke 452	
Treatment. Stroke 2018; 49(4):945–51. 453	
18. Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. 454	
Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and 455	
challenges. Lancet Neurol 2017; 16(3):227–37. 456	
19. Calderon VJ, Kasturiarachi BM, Lin E, Bansal V, Zaidat OO. Review of the Mobile 457	
Stroke Unit Experience Worldwide. Interv Neurol 2018; 7(6):347–58. 458	
20. Audebert H, Fassbender K, Hussain MS, et al. The PRE-hospital Stroke Treatment 459	
Organization. Int J stroke:official journal of the International Stroke Society 2017; 460	
12(9):932–40. 461	
21. Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with 462	
stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet 463	
Neurol 2012; 11(5):397–404. 464	
11	
	
22. Kunz A, Ebinger M, Geisler F, et al. Functional outcomes of pre-hospital 465	
thrombolysis in a mobile stroke treatment unit compared with conventional care: an 466	
observational registry study. Lancet Neurol 2016; 15:1035–43. 467	
23. Ebinger M, Winter B, Wendt M, et al. Effect of the use of ambulance-based 468	
thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical 469	
trial. JAMA 2014; 311(16):1622–31. 470	
24. Zhao H, Coote S, Pesavento L, et al. Prehospital idarucizumab prior to intravenous 471	
thrombolysis in a mobile stroke unit. Int J stroke 2018; 14(3):265–9. 472	
25. Shuaib A, Amlani S, Kalashyan H, et al. Mobile stroke unit triage of patients with a 473	
suspected stroke: a novel solution to reducing suspected stroke admissions in busy 474	
emergency departments. BMJ Innovations 2018; 4(2):54. 475	
26. Helwig SA, Ragoschke-Schumm A, Schwindling L, et al. Prehospital Stroke 476	
Management Optimized by Use of Clinical Scoring vs Mobile Stroke Unit for Triage 477	
of Patients With Stroke: A Randomized Clinical Trial. JAMA Neurol. 2019 Sep 3: 478	
e192829. Published online 2019 Sep 3. doi: 10.1001/jamaneurol.2019.2829)  479	
27. Wendt M,  Ebinger M,  Kunz A, et al, for the STEMO Consortium. Improved 480	
Prehospital Triage of Patients With Stroke in a Specialized Stroke Ambulance. Stroke. 481	
2015; 46:740–745 482	
28. Dietrich M, Walter S, Ragoschke-Schumm A, et al. Is prehospital treatment of acute 483	
stroke too expensive? An economic evaluation based on the first trial. Cerebrovasc 484	
Dis (Basel, Switzerland) 2014; 38(6):457–63. 485	
29. Gyrd-Hansen D, Olsen KR, Bollweg K, Kronborg C, Ebinger M, Audebert HJ. Cost-486	
effectiveness estimate of prehospital thrombolysis: results of the PHANTOM-S study. 487	
Neurology 2015; 84(11):1090–7. 488	
30. Kobayashi A, Czlonkowska A, Ford GA, et al. European Academy of Neurology and 489	
European Stroke Organization consensus statement and practical guidance for pre-490	
hospital management of stroke. Eur J Neurol 2018; 25:425–33. doi: 491	
10.1111/ene.13539. 492	
31. Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the 493	
establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000; 494	
283:3102–3109. 495	
32. Ringelstein EB, Chamorro A, Kaste M, et al ESO Stroke Unit Certification 496	
Committee. European Stroke Organisation recommendations to establish a stroke unit 497	
and stroke center. Stroke 2013; 44:828–840. 498	
33. Goyal M, Kurz KD, Fisher M. Organization of Endovascular Thrombectomy: The 499	
Need for a 2-Tier System. Stroke 2019; 50(6):1325-1326.  500	
34. Mereoja A, Roine RO, Kaste M, et al. Effectiveness of primary and comprehensive 501	
stroke centers. PERFECT Stroke: a nationwide observational study from Finland. 502	
Stroke 2010; 41:1102–1107. 503	
35. Man S, Cox M, Patel P, Smith EE, et al. Differences in Acute Ischemic Stroke Quality 504	
of Care and Outcomes by Primary Stroke Center Certification Organization. Stroke 505	
2017; 48:412–419.  506	
36. Man S, Zhao X, Uchino K, et al. Comparison of Acute Ischemic Stroke Care and 507	
Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the 508	
United States. Circ Cardiovasc Qual Outcomes 2018 Jun; 11(6):e004512. doi: 509	
10.1161/CIRCOUTCOMES.117.004512. 510	
37. Norrving B, Barrick J, Davalos A, et al; on behalf of the Action Plan for Stroke in 511	




38. Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. 514	
Cochrane Database Syst Rev 2013; 9: CD000197. 515	
39. Cadilhac D, Andrew N, Lannin N, et al. Quality of acute care and long-term quality of 516	
life and survival: the Australian Stroke Clinical Registry. Stroke 2017; 48(4):1026–517	
1032. 518	
40. Morris S, Ramsay AIG, Boaden RJ, et al. Impact and sustainability of centralising 519	
acute stroke services in English metropolitan areas: retrospective analysis of hospital 520	
episode statistics and stroke national audit data. BMJ 2019; 364: l1. 521	
41. Busingye D, Kilkenny MF, Purvis T, et al.  Is length of time in a stroke unit 522	
associated with better outcomes for patients with stroke in Australia? An 523	
observational study.  BMJ Open 2018; 8:e022536. doi: 10.1136/bmjopen–2018–524	
022536 525	
42. Cadilhac, DA, Kilkenny, MF, Andrew, NE et al. Hospitals admitting at least 100 526	
patients with stroke a year should have a stroke unit: a case study from Australia. 527	
BMC Health Serv Res 2017; 17:212. https://doi.org/10.1186/s12913–017–2150–2 528	
43. Royal College of Physicians. Sentinel Stroke National Audit Programme (SSNAP) 529	
Clinical Audit, Public Report. London: Royal College of Physicians, 2016. 530	
44. Hafsteinsdottir TB, Vergunst M, Lindeman E, Schuurmans M. Educational needs of 531	
patients with a stroke and their caregivers: a systematic review of the literature.  532	
Patient Educ Couns 2011; 85(1):14–25. 533	
45. McKevitt C, Fudge N, Redfern J, et al. Self‐reported long‐term needs after stroke.  534	
Stroke 2011; 42(5):1398–403. 535	
46. Forster A, Dickerson J, Young J, et al. A structured training programme for caregivers 536	
of inpatients after stroke (TRACS): a cluster randomised controlled trial and cost-537	
effectiveness analysis. Lancet 2013; 382(9910):2069–76.  538	
47. Langhorne P and Baylan S. Early Supported Discharge Trialists. Early supported 539	
discharge services for people with acute stroke. Cochrane Database Syst Rev 2017; 7: 540	
CD000443. 541	
48. Langhorne P, Widen-Holmqvist L. Early supported discharge after stroke. J Rehabil 542	
Med 2007; 39(2):103–108. 543	
49. Bladin CF, Cadilhac DA. Effect of telestroke on emergent stroke care and stroke 544	
outcomes. Stroke 2014; 45(6):1876–80. 545	
50. Levine SR, Gorman M. "Telestroke" : the application of telemedicine for stroke. 546	
Stroke 1999; 30(2):464–9. 547	
51. Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use 548	
of telemedicine within stroke systems of care: a scientific statement from the 549	
American Heart Association/American Stroke Association. Stroke 2009; 40(7):2616–550	
34. 551	
52. Wechsler LR, Demaerschalk BM, Schwamm LH, et al. Telemedicine Quality and 552	
Outcomes in Stroke A Scientific Statement for Healthcare Professionals From the 553	
American Heart Association/American Stroke Association. Stroke 2017; 48(1):E3–554	
E25. 555	
53. Bagot K, Moloczij N, Arthurson L, et al. Nurses' Role in Implementing and 556	
Sustaining Acute Telemedicine: A Mixed-Methods, Pre-Post Design Using an 557	
Extended Technology Acceptance Model. J Nurs Scholarsh. 202052(1):34-46.  558	
54. Bagot KL, Cadilhac DA, Kim J, et al. Transitioning from a single-site pilot project to 559	
a state-wide regional telehealth service: The experience from the Victorian Stroke 560	
Telemedicine programme. J Telemed Telecare 2017; 23(10):850–5. 561	
13	
	
55. Schwamm LH, Audebert HJ, Amarenco P, et al. Recommendations for the 562	
implementation of telemedicine within stroke systems of care: a policy statement 563	
from the American Heart Association. Stroke 2009; 40(7):2635–60. 564	
56. Muller-Barna P, Schwamm LH, Haberl RL. Telestroke increases use of acute stroke 565	
therapy. Curr Opin Neurol 2012; 25(1):5–10. 566	
57. Laver KE, Schoene D, Crotty M, George S, Lannin NA, Sherrington C. 567	
Telerehabilitation services for stroke. Cochrane Database Syst Rev 2013; 12: 568	
CD010255. 569	
58. Appleby E, Gill ST, Hayes LK, Walker TL, Walsh M, Kumar S. Effectiveness of 570	
telerehabilitation in the management of adults with stroke: A systematic review. PLoS 571	
One 2019; 14(11): e0225150. 572	
59. Schwamm LH, Rosenthal ES, Hirshberg A, et al. Virtual TeleStroke support for the 573	
emergency department evaluation of acute stroke. Acad Emerg Med: official journal 574	
of the Society for Academic Emergency Medicine 2004; 11(11):1193–7. 575	
60. Audebert HJ, Kukla C, Clarmann von Claranau S, et al. Telemedicine for safe and 576	
extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative 577	
Stroke Care (TEMPiS) in Bavaria. Stroke 2005; 36(2):287–91. 578	
61. Handschu R, Littmann R, Reulbach U, et al. Telemedicine in emergency evaluation of 579	
acute stroke: interrater agreement in remote video examination with a novel 580	
multimedia system. Stroke 2003; 34(12):2842–6. 581	
62. Demaerschalk BM, Bobrow BJ, Raman R, et al. CT interpretation in a telestroke 582	
network: agreement among a spoke radiologist, hub vascular neurologist, and hub 583	
neuroradiologist. Stroke 2012; 43(11):3095–7. 584	
63. Puetz V, Bodechtel U, Gerber JC, et al. Reliability of brain CT evaluation by stroke 585	
neurologists in telemedicine. Neurology 2013; 80(4):332–8. 586	
64. Meyer BC, Raman R, Hemmen T, et al. Efficacy of site-independent telemedicine in 587	
the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 588	
2008; 7(9):787–95. 589	
65. Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine for 590	
stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital 591	
Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials. 592	
Telemed J E-Health: the official journal of the American Telemedicine Association 593	
2012; 18(3):230–7. 594	
66. Audebert HJ, Kukla C, Vatankhah B, et al. Comparison of tissue plasminogen 595	
activator administration management between Telestroke Network hospitals and 596	
academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in 597	
Bavaria/Germany. Stroke 2006; 37(7):1822–7. 598	
67. Schwab S, Vatankhah B, Kukla C, et al. Long-term outcome after thrombolysis in 599	
telemedical stroke care. Neurology 2007; 69(9):898–903. 600	
68. Bladin CF, Kim J, Bagot K, et al. Improving acute stroke care in regional hospitals: 601	
early impact of the Victorian Stroke Telemedicine program. Med J Aust 2020; 602	
Provisional acceptance November 26th. 603	
69. Hubert GJ, Meretoja A, Audebert H, et al. Comparison of stroke thrombolysis rates 604	
and delays in a centralized (Helsinki, Finland) and decentralized (Tempis Telestroke 605	
Unit Network, Germany) setting. Int J stroke 2014; 9:41–331. 606	
70. Nguyen-Huynh MN, Klingman JG, Avins AL, et al. Novel Telestroke Program 607	
Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated 608	
Healthcare System. Stroke 2018; 49(1):133–9. 609	
71. Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL. Effects of the 610	
implementation of a telemedical stroke network: the Telemedic Pilot Project for 611	
14	
	
Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 2006; 612	
5(9):742–8. 613	
72. Audebert HJ, Schultes K, Tietz V, et al. Long-term effects of specialized stroke care 614	
with telemedicine support in community hospitals on behalf of the Telemedical 615	
Project for Integrative Stroke Care (TEMPiS). Stroke 2009; 40(3):902–8. 616	
73. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ. The cost-617	
effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology 2011; 618	
77(17):1590–8. 619	
74. Schenkel J1, Reitmeir P, Von Reden S, Holle R, Boy S, Haberl R, Audebert H. Cost 620	
Analysis of Telemedical Treatment of Stroke. Gesundheitswesen. 2013;75(7):405-12.  621	
75. Switzer JA, Demaerschalk BM, Xie J, Fan L, Villa KF, Wu EQ. Cost-effectiveness of 622	
hub-and-spoke telestroke networks for the management of acute ischemic stroke from 623	
the hospitals' perspectives. Circ Cardiovasc Qual Outcomes 2013; 6(1):18–26. 624	
76. Kepplinger J, Dzialowski I, Barlinn K, et al. Emergency transfer of acute stroke 625	
patients within the East Saxony telemedicine stroke network: a descriptive analysis. 626	
Int J stroke: official journal of the International Stroke Society 2014; 9(2):160–5. 627	
77. Bergrath S, Reich A, Rossaint R, et al. Feasibility of prehospital teleconsultation in 628	
acute stroke - a pilot study in clinical routine. PLoS One 2012; 7(5): e36796. 629	
78. Geisler F, Kunz A, Winter B, et al. Telemedicine in Prehospital Acute Stroke Care. J 630	
Am Heart Assoc 2019; 8(6): e011729. 631	
79. Liman TG, Winter B, Waldschmidt C, et al. Telestroke Ambulances in Prehospital 632	
Stroke Management. Stroke 2012; 43:2086–2090. 633	
80. Itrat A, Taqui A, Cerejo R, et al. Telemedicine in Prehospital Stroke Evaluation and 634	
Thrombolysis: Taking Stroke Treatment to the Doorstep. JAMA neurology 2016; 635	
73(2):162–8. 636	
81. Wu TC, Parker SA, Jagolino A, et al. Telemedicine can replace the Neurologist on a 637	
Mobile Stroke Unit. Stroke 2017; 48(2):493–6. 638	
82. Winter B, Wendt M, Waldschmidt C, et al. 4G versus 3G-enabled telemedicine in 639	
prehospital acute stroke care. Int J stroke: official journal of the International Stroke 640	
Society 2019; 14(6):620–9. 641	
83. Grunwald IQ, Ragoschke-Schumm A, Kettner M, et al. First Automated Stroke 642	
Imaging Evaluation via Electronic Alberta Stroke Program Early CT Score in a 643	
Mobile Stroke Unit. Cerebrovasc Dis (Basel, Switzerland) 2016; 42(5–6):332–8. 644	
84. Weber JE, Ebinger M, Rozanski M, et al. Prehospital thrombolysis in acute stroke: 645	
results of the PHANTOM-S pilot study. Neurology 2013; 80(2):163–8. 646	
85. Pollock A, Campbell P, Baer G, et al. Challenges in integrating international evidence 647	
relating to stroke rehabilitation: experiences from a Cochrane systematic review. Int J 648	
stroke: official journal of the International Stroke Society 2014; 9(8):965–7. 649	
86. Brady MC, Kelly H, Godwin J, Enderby P, Campbell P. Speech and language therapy 650	
for aphasia following stroke. Cochrane Database Syst Rev 2016; 6: CD000425. 651	
87. Legg LA, Lewis SR, Schofield-Robinson OJ, Drummond A, Langhorne P. 652	
Occupational therapy for adults with problems in activities of daily living after stroke. 653	
Cochrane Database Syst Rev 2017; 7: CD003585. 654	
88. Sarfo FS, Ulasavets U, Opare-Sem OK, Ovbiagele B. Tele-Rehabilitation after 655	
Stroke: An Updated Systematic Review of the Literature. J Stroke Cerebrovasc Dis 656	
2018; 27(9):2306–18. 657	
89. Béjot Y, Mehta Z, Giroud M, Rothwell PM. Impact of Completeness of 658	
Ascertainment of Minor Stroke on Stroke Incidence Implications for Ideal Study 659	
Methods. Stroke 2013; 44:1796–1802. 660	
15	
	
90. Zerna C, Thomalla G, Campbell BCV, Rha J, Hill MD. Current practice and future 661	
directions in the diagnosis and acute treatment of ischaemic stroke. Lancet 2018; 662	
392:1247–56. 663	
91. Mokin M, Snyder KV, Siddiqui AH, Levy EI, Hopkins LN. Recent Endovascular 664	
Stroke Trials and Their Impact on Stroke Systems of Care. J Am Coll Cardiol 2016; 665	
67(22):2645–55. 666	
92. Holodinsky JK, Williamson TS, Kamal N, Mayank D, Hill MD, Goyal M. Drip and 667	
Ship Versus Direct to Comprehensive Stroke Center: Conditional Probability 668	
Modeling. Stroke 2017;48:233–238 669	
93. Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, Reeves MJ, Towfighi A, 670	
Whiteley WN,  Zahuranec DB, on behalf of the American Heart Association Stroke 671	
Council. Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion 672	
in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines 673	
for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 674	
2018;49:e111–e122. 675	
94. Schlemm L, Endres M, Scheitz JF, Ernst M, Nolte CH, Schlemm E. Comparative 676	
Evaluation of 10 Prehospital Triage Strategy Paradigms for Patients With Suspected 677	
Acute Ischemic Stroke. Journal of the American Heart Association. 2019;8:e012665. 678	
95. Cadilhac DA, Kim J, Lannin NA, et al. National stroke registries for monitoring and 679	
improving the quality of hospital care: A systematic review. Int J stroke: official 680	
journal of the International Stroke Society 2016; 11(1):28–40. 681	
96. Asplund K, Hulter Asberg K, Appelros P, et al. The Riks-Stroke story: building a 682	
sustainable national register for quality assessment of stroke care. Int J stroke: official 683	
journal of the International Stroke Society 2011; 6(2):99–108. 684	
97. Silver FL, Kapral MK, Lindsay MP, Tu JV, Richards JA. International experience in 685	
stroke registries: lessons learned in establishing the Registry of the Canadian Stroke 686	
Network. Am J Prev Med 2006; 31(6 Suppl 2):S235–7.	 687	
98. Ganesh A, Lindsay P, Fang J, Kapral MK, Côté R, Joiner I, Hakim AM, Hill MD. 688	
Integrated systems of stroke care and reduction in 30-day mortality. Neurology Mar 689	
2016, 86 (10) 898-904. 690	
